Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | TAF1A |
| Upstream (Parents) |
|---|
| (<<) CCNB1 → TAF1A |
| (<<) CEBPA → TAF1A |
| (<<) CTSF → TAF1A |
| (<<) CYP1A2 → TAF1A |
| (<<) DDX18 → TAF1A |
| (<<) E2F3 → TAF1A |
| (<<) HK2 → TAF1A |
| (<<) KIAA0020 → TAF1A |
| (<<) MAFF → TAF1A |
| (<<) RPL35 → TAF1A |
| (<<) TAGLN2 → TAF1A |
| (<<) TUBA1B → TAF1A |
| Downstream (Children) |
|---|
| TAF1A → CHAF1A (>>) |
| TAF1A → DUSP2 (>>) |
| TAF1A → EBP (>>) |
| TAF1A → FZD8 (>>) |
| TAF1A → GNB2L1 (>>) |
| TAF1A → MLXIPL (>>) |
| TAF1A → NPC1 (>>) |
| TAF1A → PFDN2 (>>) |
| TAF1A → ROR1 (>>) |
| TAF1A → RPS6KB1 (>>) |
| TAF1A → RRP15 (>>) |
| TAF1A → SMAD2 (>>) |
| TAF1A → TMEM158 (>>) |
